Clario provides comprehensive endpoint technologies and solutions for clinical trial management, helping sponsors assess efficacy, safety, and patient quality of life. Leveraging a database of over 5,000 imaging studies, the company offers validated response criteria and integrated data analytics to streamline endpoint selection and evidence generation.
Funding
Funding not disclosed
Founders
Product
Problem
Designing clinical trials that accurately measure treatment efficacy, safety, and patient quality of life is complex, often hindered by limited access to validated endpoint technologies and inconsistent data integration across sites.
Solution
Clario offers a suite of endpoint technologies that combine a large imaging study database with scientifically validated response criteria to support precise efficacy assessments. Their safety solutions embed patient‑centric monitoring tools to ensure consistent safety data capture throughout the trial. Quality‑of‑life measures are integrated via standardized instruments that evaluate mental health and daily functioning, enabling comprehensive impact analysis. All data are processed through a unified analytics platform that streamlines endpoint selection, harmonizes site‑based, hybrid, and decentralized trial data, and generates regulatory‑ready evidence. The collaborative model pairs sponsors with Clario’s clinical trial experts to tailor endpoint strategies that align with therapeutic goals and regulatory expectations.
Target Audience
Clario’s primary customers are pharmaceutical and biotech sponsors, as well as contract research organizations that require robust, scientifically validated endpoint solutions for efficacy, safety, and patient‑reported outcomes in their clinical programs.
Features
- Library of >5,000 imaging studies with pre‑validated response criteria for multiple therapeutic areas
- Integrated safety monitoring modules that capture adverse events and patient‑reported outcomes in real time
- Standardized quality‑of‑life assessment tools covering mental health and functional status
- Centralized analytics platform that consolidates data from site, hybrid, and decentralized sources for consistent endpoint evaluation
- Regulatory‑focused evidence generation workflow ensuring compliance with global standards
- Collaborative trial design support from a team of clinical endpoint scientists and trial management experts